Incipient cardiovascular autonomic imbalance revealed by wavelet analysis of heart rate variability in Type 2 diabetic patients

Diabetic Medicine

Volumn 24, Issue 1, 2007, Pages 18-26

  Urbancic Rovan V ^a   Meglic B ^a   Stefanovska, A ^b,c   Bernjak, A ^b   Azman Juvan K ^a   Kocijancic A ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Autonomic nervous system; Cardiac autonomic neuropathy; Heart rate variability; Non linear dynamics

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; HEART CONTRACTION; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARRHYTHMIA; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HEART FUNCTION TESTS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 33846185514     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02019.x     Document Type: Article

References (42)

1. Sztajzel J. Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss Med Wkly 2004; 134: 514-522.
2. Gerritsen J, Dekker JM, TenVoorde BJ, Kostense PJ, Heine RJ, Bouter LM et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 2001; 24: 1793-1798.
3. Risk M, Bril V, Broadbridge C, Cohen A. Heart rate variability measurement in diabetic neuropathy: review of methods. Diabetes Technol Ther 2001; 3: 63-76.
4. Camm AJ, Malik M, Bigger JT, Breithardt G, Cerutti S, Cohen RJ et al. (Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology). Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-1065.
5. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat to beat cardiovascular control. Science 1981; 213: 220-222.
6. Lotriè MB, Stefanovska A, Štajer D, Urbanèiè- Rovan V. Spectral components of heart rate variability determined by wavelet analysis. Physiol Meas 2000; 21: 441-457.
7. Soderstrom T, Stefanovska A, Veber M, Svensson H. Involvement of sympathetic nerve activity in skin blood flow oscillations in humans. Am J Physiol Heart Circ Physiol 2003; 284: H1638-1646.
8. Bajrovic F, Cencur M, Hozic M, Ribaric S, Stefanovska A. The contribution of lumbar sympathetic neurones activity to rat's skin blood flow oscillations. Pflugers Arch 2000; 439: R158-160.
9. Stefanovska A, Bracic M. Physics of the human cardiovascular system. Contemp Physics 1999; 40: 31-55.
10. Freeman R, Saul JP, Roberts MS, Berger RD, Broadbridge C, Cohen RJ. Spectral analysis of heart rate in diabetic autonomic neuropathy. A comparison with standard tests of autonomic function. Arch Neurol 1991; 48: 185-190.
11. Howorka K, Pumprla J, Schabmann A. Optimal parameters of short-term heart rate spectrogram for routine evaluation of diabetic cardiovascular autonomic neuropathy. J Auton Nerv Syst 1998; 69: 164-172.
12. Ziegler D, Laux G, Dannehl K, Spuler M, Muhlen H, Mayer P, Gries FA. Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med 1992; 9: 166-175.
13. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-1579.
14. Bellavere F, Balzani I, De Masi G, Carraro M, Carenza P, Cobelli C et al. Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy. Diabetes 1992; 41: 633-640.
15. Yamamoto M, Yamasaki Y, Kodama M, Matsuhisa M, Kishimoto M, Ozaki H et al. Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes. Diabetes Care 1999; 22: 2072-2077.
16. Pagani M, Malfatto G, Pierini S, Casati R, Masu AM, Poli M et al. Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst 1988; 23: 143-153.
17. Julu P. Vagolytic effect of diabetes mellitus. Brain 1993; 116: 485-492.
18. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987-1998. Circulation 2003; 107: 2190-2195.
19. Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 2002; 106: 2659-2665.
20. Flanagan DE, Vaile JC, Petley GW, Moore VM, Godsland IF, Cockington RA et al. The autonomic control of heart rate and insulin resistance in young adults. J Clin Endocrinol Metab 1999; 84: 1263-1267.
21. Fiorentini A, Perciaccante A, Paris A, Serra P, Tubani L. Circadian rhythm of autonomic activity in non diabetic offsprings of type 2 diabetic patients. Cardiovasc Diabetol 2005; 4: 15.
22. Morlet J. Sampling theory and wave propagation. In Chen CH ed. NATO 575 ASI Series, Issues in Acoustic Signal/Image Processing and Recognition, Vol. 1. Berlin: Springer-Verlag 1983: 233-261.
23. Hopf HB, Skyschally A, Heusch G, Peters J. Low-frequency spectral power of heart rate variability is not a specific marker of cardiac sympathetic modulation. Anesthesiology 1995; 82: 609-619.
24. Lindqvist A, Parviainen P, Kolari P, Tuominen J, Valimaki I, Antila K et al. A non-invasive method for testing neural circulatory control in man. Cardiovasc Res 1989; 23: 262-272.
25. Mortara A, Sleight P, Pinna GD, Maestri R, Prpa A, La Rovere MT et al. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. Circulation 1997; 96: 246-252.
26. Bernardi L, Valle F, Coco M, Calciati A, Sleight P. Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. Cardiovasc Res 1996; 32: 234-237.
27. Manzella D, Paolisso G. Cardiac autonomic activity and type 2 diabetes mellitus. Clin Sci (Lond) 2005; 108: 93-99.
28. Davrath LR, Goren Y, Pinhas I, Toledo E, Akselrod S. Early autonomic malfunction in normotensive individuals with a genetic predisposition to essential hypertension. Am J Physiol Heart Circ Physiol 2003; 285: H1697-1704.
29. Zhang R, Iwasaki K, Zuckerman JH, Behbehani K, Crandall CG, Levine BD. Mechanism of blood pressure and R-R variability: insights from ganglion blockade in humans. J Physiol 2002; 543: 337-348.
30. Carnethon MR, Jacobs DR Jr, Sidney S, Liu K. CARDIA study. Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. Diabetes Care 2003; 26: 3035-3041.
31. Laitinen T, Vauhkonen IK, Niskanen LK, Hartikainen JE, Lansimies EA, Uusitupa MI et al. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes 1999; 48: 1295-1299.
32. Frontoni S, Bracaglia D, Baroni A, Pellegrini F, Perna M, Cicconetti E et al. Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients. Hypertension 2003; 41: 1223-1227.
33. Valensi PE, Johnson NB, Maison-Blanche P, Extramania F, Motte G, Coumel P. Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular repolarization in diabetic patients. Diabetes Care 2002; 25: 918-923.
34. Sayer JW, Marchant B, Gelding SV, Cooper JA, Timmis AD. Autonomic dysfunction is related to impaired pancreatic beta cell function in patients with coronary artery disease. Heart 2000; 83: 210-216.
35. Weston PJ, Panerai RB, McCullough A, McNally PG, James MA, Potter JF et al. Assessment of baroreceptor-cardiac reflex sensitivity using time domain analysis in patients with IDDM and the relation to left ventricular mass index. Diabetologia 1996; 39: 1385-1391.
36. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 1998; 41: 416-423.
37. Amthor KF, Dahl-Jorgensen K, Berg TJ, Heier MS, Sandvik L, Aagenaes O et al. The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study. Diabetologia 1994; 37: 579-584.
38. Larsen JR, Sjoholm H, Berg TJ, Sandvik L, Brekke M, Hanssen KF et al. Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes. Diabetes Care 2004; 27: 963-966.
39. Burger AJ, Weinrauch LA, D'Elia JA, Aronson D. Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. Am J Cardiol 1999; 84: 687-691.
40. Makimattila S, Schlenzka A, Mantysaari M, Bergholm R, Summanen P, Saar P et al. Predictors of abnormal cardiovascular autonomic function measured by frequency domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes. Diabetes Care 2000; 23: 1686-1693.
41. Athyros VG, Didangelos TP, Karamitsos DT, Papageorgiou AA, Boudoulas H, Kontopoulos AG. Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy. Acta Cardiol 1998; 53: 201-209.
42. Malik RA, Williamson S, Abbott C, Carrington AL, Iqbal J, Schady W, Boulton AJ. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 1998; 352: 1978-1981.